Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children

Phase 3Active Not RecruitingNCT07398261

Menoufia University151 enrolled

Overview

This phase 3 clinical trial will compare use of individual treatment with mirabegron or desmopressin and their combination for treatment of non-monosymptomatic nocturnal enuresis in children

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

151

Conditions

Treatment of Non-monosymptomatic Nocturnal Enuresis

Interventions

Mirabegron 25 MGDRUG

Evaluate the efficacy of individual mirabegron or in combination for treatment of non-monosymptomatic nocturnal enuresis in children

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: \- Non-monosymptomatic nocturnal enuresis Exclusion Criteria: * monosymptomatic nocturnal enuresis

Locations (1)

Menoufia faculty of medicine

Shibīn al Kawm, Monufia Governorate, Egypt

Outcomes

Primary Outcomes

Partial or complete response

Time frame: 18 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.